Author

S. McCann

King's College London

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Ramirez-Abreu· 1 shared A. Rex· 1 shared Anna BlasiiD· 1 shared Borja BlancoiD· 1 shared Chiara BulgarelliiD· 1 shared Clare E. ElwelliD· 1 shared D. Schulze· 1 shared E. Garcia-Alfonso· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Ramirez-Abreu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Examining Cross-Paradigm fNIRS Brain Activity in Neonates across The Gambia and UK

Isobel Greenhalgh, Borja Blanco, Chiara Bulgarelli, Ebrima Mbye, Ebou Touray, Maria Rozhko, Laura Katus, Nathan J. Hayes, S. McCann, Sophie E. Moore, Clare E. Elwell, Anna Blasi, Sarah Lloyd‐Fox, the BRIGHT Project Team

This study examines cross-paradigm fNIRS brain activity in neonates from The Gambia and UK to identify context-specific neurodevelopmental markers.

bioRxiv · Jul 28, 2025 · PreprintNeuroscience

A randomized, controlled, two-center preclinical trial assessing the efficacy of a new benzodiazepine-dihydropyridine hybrid molecule (JM-20) in rodent models of ischemic stroke

J. Ramirez-Sanchez, A. Rex, S. McCann, D. Schulze, M. Wong-Guerra, L. A. Fonseca-Fonseca, E. Garcia-Alfonso, A. Ramirez-Abreu, R. Limonta, M. Dopatka, L. Mosch, Y. Nunez-Figueredo, U. Dirnagl

This paper reports a two-center preclinical trial of JM-20, a benzodiazepine-dihydropyridine hybrid, showing modest neuroprotective effects in some rodent models of ischemic stroke but not in others.

bioRxiv · Mar 8, 2024 · PreprintPharmacology & Toxicology